3D Medical Printing Systems Market Scope
Over the past few years, The 3D medical printing system technology is creating big opportunities of growth by helping pharmaceutical and medical companies by enabling rapid production of medical implants, creating more specific drugs, and changing the way that surgeons and medical practitioners plan procedures is increasing the demand for 3D medical printing system in the markets. The 3D-printing technology permits to offer to the surgeon a physical 3D model of the desired patient anatomy that could be used to accurately plan the surgical approach along with cross-sectional imaging or, alternatively, modeling custom prosthetics or surgical tool based on patient-specific anatomy. Moreover increasing demand for 3D medical printing is to improve the daily work of all medical professionals and allowing them to save lives more and more is one of the key driving factors of growth.
Attributes | Details |
---|
Study Period | 2018-2028 |
Base Year | 2022 |
Unit | Value (USD Million) |
Key Companies Profiled | Arcam AB (Sweden), Anatomics Pty Ltd (Australia), Biomedical Modeling Inc. (United States), Carbon, Inc. (United States), SLM Solutions Group AG (Germany), Organovo Holdings, Inc. (United States), Stratasys Ltd. (Israel and United States), 3D Systems Corporation (United States), Materialise NV (Belgium), EnvisionTEC GmbH (Germany) and EOS GmbH Electro Optical Systems (Germany) |
CAGR | % |
The global 3D Medical Printing Systems market is fragmented due to the presence of regional and global manufacturers. The level of competition among the companies in the 3D Medical Printing Systems market is intense and manufacturers focus on developing new technologies and offering customized products to the customers. In the coming years, manufacturers will also develop new partnerships to spread their product reach to more customers globally. Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global 3D Medical Printing Systems market throughout the predicted period.
Arcam AB (Sweden), Anatomics Pty Ltd (Australia), Biomedical Modeling Inc. (United States), Carbon, Inc. (United States), SLM Solutions Group AG (Germany), Organovo Holdings, Inc. (United States), Stratasys Ltd. (Israel and United States), 3D Systems Corporation (United States), Materialise NV (Belgium), EnvisionTEC GmbH (Germany) and EOS GmbH Electro Optical Systems (Germany) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are Renishaw plc (United Kingdom), Concept Laser GmbH (Germany), 3T RDP, Ltd. (United Kingdom) and Prodways (France).
About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from the total available market.
Segmentation Overview
The study have segmented the market of Global 3D Medical Printing Systems market by Type , by Application (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Academic Institutions and Biotech and Pharma Companies) and Region with country level break-up.
On the basis of geography, the market of 3D Medical Printing Systems has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).
region held largest market share in the year 2022.
Market Leaders and their expansionary development strategies
In July 2020 Medtronic Ireland based company announced an acquisition with Medicrea for the implication of 3D printing medical technology. Medicrea’s devoted 3D developed facility will fit right into the flow of Medtronic’s activities as they expand upon their ability to develop custom medical products through the use of 3D printing
In September 2020 EnvisionTEC, Germany Based company has launched and completed a trial of their new products named EnvisionTEC 3D printed Nasopharyngeal (NP) Swabs for COVID-19 testing. For this, the company has worked with Beth Israel Deaconess Medical Center for developing a swab design and materials printed on its Envision One cDLM 3D printer., and In August 2020 Axial 3D United kingdom-based company has announced that the company will offer insight into the lungs of a Covid-19 patient with 3D printing first in the world. Axial3D worked with the respiratory players at Belfast Health and Social Care Trust to manufacture a 1:1 scale 3D model of an actual Covid-19 patient’s lungs. The association was able to do this by using CT scans taken from day 14 of the infection.
"FDA has developed this guidance to provide the Agency’s initial thinking on technical considerations specific to devices using additive manufacturing, the broad category of manufacturing encompassing 3-dimensional (3D) printing. This guidance is broadly organized into two topic areas: Design and Manufacturing Considerations (Section V) and Device Testing Considerations (Section VI)." and “Regulation (EU) 2017/745 of the European Parliament and of the Council of the 5 April 2017 [74]. They are defined as follow: “any device specifically made in accordance with a written prescription of any person authorized by national law by virtue of that person’s professional qualifications which gives, under that person’s responsibility, specific design characteristics, and is intended for the sole use of a particular patient exclusively to meet their individual conditions and needs”.
Influencing Trend:
Conferences and Symposiums and partnerships
Market Growth Drivers:
Growing Public-Private Funding for 3D Printing Activities and government involvement in the medical sector is the key driving factor of growth, Technological Advancements in 3D Printing and Growing adoption of Applications of 3D Printing in the Healthcare Industry
Challenges:
Critical reimbursement policies and Copyright and patent infringement concerns
Restraints:
High costs associated with the printers and Lack of lack of structured regulatory
Opportunities:
Expiry of Key Patents in the 3D Printing Industry and Growing Demand for Organ Transplant
Key Target Audience
New Entrants/Investors, Analysts and Strategic Business Planners, 3D Medical Printing Systems Manufacturer, Raw Material Suppliers, Dealers, Suppliers, Traders, and Distributors, Venture Capitalists and Private Equity Firms, Government Regulatory and Research Organizations and End-Use Industry